Major shareholder announcement – Swedbank Robur Fonder AB
03 Avril 2024 - 4:05PM
Major shareholder announcement – Swedbank Robur Fonder AB
ANNOUNCEMENT NO. 259
Major shareholder announcement
Major shareholder announcement – Swedbank
Robur Fonder AB
Pursuant to Section 38 of the Danish Capital
Markets Act, it is hereby announced that Swedbank Robur Fonder AB
has informed ChemoMetec A/S that Swedbank Robur Fonder AB on 2
April 2024, decreased its holding of shares and voting rights to
below 5% of the total share capital and voting rights in ChemoMetec
A/S.
Additional information
Niels Høy Nielsen, CFOTelephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets
instruments for cell counting and a wide range of other
measurements. ChemoMetec’s instruments are marketed to the
pharmaceutical, biotech and agricultural industries worldwide.
ChemoMetec’s customers include some of the world’s leading
pharmaceutical companies, such as Novartis, Novo Nordisk, H.
Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on
Nasdaq OMX Copenhagen. For more information, go to
www.chemometec.com
Chemometec AS (TG:CHY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Chemometec AS (TG:CHY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024